Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia
JAMA Network Open · 14.05.2025 · 8 (5) · e259952
DOI: 10.1001/jamanetworkopen.2025.9952 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 14.05.2025. Verfasst von Elena J Ladas und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity, Overweight, Obesity. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance There are conflicting data on the association of overweight or obesity with clinical outcomes in childhood acute lymphoblastic leukemia (ALL). The duration of exposure to overweight or obesity may be a better indicator of the risk of poorer outcomes.
Objective
To determine the association of the duration of overweight or obesity with treatment-related toxic effects, minimal residual disease, relapse, and survival in childhood ALL. Design, Setting, and Participants In this prospective cohort study, fluctuations in z scores of body mass index (BMI) for age from diagnosis to the end of treatment (EOT) were examined in 794 children registered on a Dana Farber Cancer Institute ALL Consortium protocol from May 31, 2005, to December 15, 2011. Height and weight were abstracted from the medical record for classification of BMI z scores at diagnosis through EOT and into survivorship. Data were analyzed from July 1 to 31, 2024. Main Outcomes and Measures The duration of overweight or obesity was defined as having overweight or obesity at 2 or more time points and compared with having overweight or obesity at no more than 1 time point. Kaplan-Meier survival curves were generated to examine association of overweight or obesity with overall survival (OS), event-free survival (EFS), and cumulative incidence of relapse.
Results
Among the 794 patients included in the analysis, the mean age at diagnosis was 6.7 (range, 1.0-17.9) years, with 441 (55.5%) being male, 136 (17.1%) Hispanic, and 553 (69.6%) non-Hispanic. The prevalence of overweight or obesity increased from 234 of 793 (29.5%) at diagnosis to 346 of 715 (48.4%) by EOT. Having overweight or obesity at baseline or developing overweight or obesity during induction was not associated with treatment-related toxic effects or higher minimal residual disease. Children with overweight or obesity at 2 or more time points experienced inferior OS (3-year OS, 93.8% vs 98.0%; P = .01), increased relapse (3-year relapse rate, 10.5% vs 5.8%; P = .02), and lower EFS (3-year EFS, 89.0% vs 93.7%; P = .02), compared with children with overweight or obesity at no more than 1 time point. Multivariable Cox proportional hazards regression models revealed an association between increased risk of death (hazard ratio [HR], 3.49; 95% CI, 1.28-9.51; P = .01) and relapse (HR, 1.92; 95% CI, 1.07-3.46; P = .03) among children with overweight or obesity at 2 or more time points. Conclusions and Relevance In this prospective cohort study of children with ALL, longer duration of overweight or obesity was associated with lower OS and EFS and higher rates of relapse, underscoring the need for interventions targeting overweight or obesity during treatment of children with ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York.
- Department of Cancer Prevention, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- Division of Hematology-Oncology, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada.
- Department of Pediatrics, University of Rochester School of Medicine, Golisano Children's Hospital at URMC, Rochester, New York.
- Department of Pediatrics, San Jorge Children's Hospital, San Juan, Puerto Rico.
- Rutgers Cancer Institute of New Jersey, New Brunswick.
Zitieren
APA
Ladas, E. J., Sheng, H., Athale, U. H., Asselin, B. L., Clavell, L. A., Cole, P. D., Flamand, Y., Leclerc, J. M., Laverdiere, C., Michon, B., Sallan, S. E., Silverman, L. B., Welch, J. J. G., Yao, S., & Kelly, K. M. (2025). Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia. JAMA Network Open, 8(5), e259952. https://doi.org/10.1001/jamanetworkopen.2025.9952
Vancouver
Ladas EJ, Sheng H, Athale UH, Asselin BL, Clavell LA, Cole PD, et al. Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia. JAMA Network Open. 2025;8(5):e259952. doi:10.1001/jamanetworkopen.2025.9952
BibTeX
@article{Ladas2025,
author = {Ladas, Elena J and Sheng, Haiyang and Athale, Uma H and Asselin, Barbara L and Clavell, Luis A and Cole, Peter D and Flamand, Yael and Leclerc, Jean-Marie and Laverdiere, Caroline and Michon, Bruno and Sallan, Stephen E and Silverman, Lewis B and Welch, Jennifer J G and Yao, Song and Kelly, Kara M},
title = {Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {5},
pages = {e259952},
doi = {10.1001/jamanetworkopen.2025.9952}
}
EUVIMED